Revelation Biosciences Statistics
Total Valuation
REVB has a market cap or net worth of $3.41 million. The enterprise value is -$8.58 million.
| Market Cap | 3.41M |
| Enterprise Value | -8.58M |
Important Dates
The next estimated earnings date is Monday, May 20, 2024, before market open.
| Earnings Date | May 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
REVB has 1.63 million shares outstanding. The number of shares has increased by 215.00% in one year.
| Shares Outstanding | 1.63M |
| Shares Change (YoY) | +215.00% |
| Shares Change (QoQ) | +8.92% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 1.96% |
| Float | 1.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.79 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.18, with zero debt.
| Current Ratio | 2.18 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.30% and return on invested capital (ROIC) is -130.22%.
| Return on Equity (ROE) | -1.30% |
| Return on Assets (ROA) | -0.80% |
| Return on Capital (ROIC) | -130.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$13,362 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.78% in the last 52 weeks. The beta is 0.12, so REVB's price volatility has been lower than the market average.
| Beta (1Y) | 0.12 |
| 52-Week Price Change | -93.78% |
| 50-Day Moving Average | 2.71 |
| 200-Day Moving Average | 14.55 |
| Relative Strength Index (RSI) | 38.65 |
| Average Volume (30 Days) | 406,920 |
Short Selling Information
The latest short interest is 32,814, so 2.01% of the outstanding shares have been sold short.
| Short Interest | 32,814 |
| Short Previous Month | 32,782 |
| Short % of Shares Out | 2.01% |
| Short % of Float | 2.02% |
| Short Ratio (days to cover) | 0.15 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.66M |
| Pretax Income | -120,254 |
| Net Income | -120,254 |
| EBITDA | -95,205 |
| EBIT | -120,254 |
| Earnings Per Share (EPS) | -$0.53 |
Balance Sheet
The company has $11.99 million in cash and no debt, giving a net cash position of $11.99 million or $7.34 per share.
| Cash & Cash Equivalents | 11.99M |
| Total Debt | n/a |
| Net Cash | 11.99M |
| Net Cash Per Share | $7.34 |
| Equity / Book Value | 6.65M |
| Book Value Per Share | 4.07 |
| Working Capital | 6.58M |
Cash Flow
| Operating Cash Flow | -7.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.29M |
| FCF Per Share | -$31.87 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
REVB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -215.00% |
| Shareholder Yield | -215.00% |
| Earnings Yield | -3.52% |
| FCF Yield | -213.50% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |